Menopause Induced Depression, Anxiety, Quality of Life, Lack of Sleep in Women: An Overview

Arivazhagan Ragasudha,Skaria Minnu,R Sambath Kumar
DOI: https://doi.org/10.22270/jddt.v11i6.5169
2021-11-14
Journal of Drug Delivery and Therapeutics
Abstract:Background: Menopause occurs between the ages of 40 and 50, and marks the end of a woman's menstrual cycle. A period of time during which a woman does not have a monthly cycle for more than 12 months is known as post-menopause. Women may suffer challenges in their daily lives during this period, such as depression, anxiety, and sleep loss, all of which can have a negative impact on their quality of life. A decrease in hormone production, such as estrogen and progesterone, can cause menopause. To treat psychological difficulties in menopausal women, drugs such as vortioxetine and paroxetine, as well as selective serotonin reuptake inhibitors (SSRI) and anti-depressants, were advised. Objective: To evaluate the effects in women how menopause inducing depression, anxiety, quality of life and lack of sleep. Methodology: The recent studies related to the aim of the review were undertaken through a literature search to evaluate the effects in women how menopause inducing depression, anxiety, quality of life and lack of sleep. Conclusion: Menopause, post-menopause, and peri-menopause are age-related causes in women who are going through the menstrual cycle. There is no need for medication during this time, but in severe cases, medications such as selective serotonin reuptake inhibitors (SSRI) and antidepressants should be administered and also for vaginal dryness and irritation Ospemifene is suggested. Many more clinical researches on the benefits of menopausal compilations will be needed in the future. Keywords: Menopause, post- menopause, depression, estrogen, progesterone
What problem does this paper attempt to address?